SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-21-009731
Filing Date
2021-02-01
Accepted
2021-02-01 08:32:14
Documents
3
Period of Report
2021-01-27
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm214860d1_8k.htm 8-K 16001
2 EXHIBIT 99.1 tm214860d1_ex99-1.htm EX-99.1 10673
3 GRAPHIC tm214860d1_ex99-1img01.jpg GRAPHIC 20007
  Complete submission text file 0001104659-21-009731.txt   55570
Mailing Address 420 LEXINGTON AVENUE, SUITE 300 NEW YORK NY 10170
Business Address 420 LEXINGTON AVENUE, SUITE 300 NEW YORK NY 10170 (212) 479-2513
Scopus BioPharma Inc. (Filer) CIK: 0001772028 (see all company filings)

IRS No.: 821248020 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39788 | Film No.: 21574788
SIC: 2834 Pharmaceutical Preparations